|
|
Volumn 49, Issue 2, 1997, Pages 641-642
|
|
Treatment of multiple sclerosis with interferon beta-1β [3] (multiple letters)
a a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1 INTERFERON;
BETA1A INTERFERON;
INTERFERON BETA SERINE;
NEUTRALIZING ANTIBODY;
PLACEBO;
RECOMBINANT BETA INTERFERON;
ANTIBODY TITER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
IMMUNOGENICITY;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
MOLECULAR WEIGHT;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
REMISSION;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0030863207
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.49.2.641-a Document Type: Letter |
|
Times cited : (1)
|
|
References (7)
|